Synthego Corp.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Helsinn Extends Akynzeo Marketing

The days of launching a start-up with hundreds of millions of dollars in series A funding to build a technology platform with no drug candidates advancing toward the clinic until years later may soon

Venture capital investment in the biopharmaceutical industry continues to be massive in terms of both the number of companies raising funds and the size of funding rounds despite the ongoing economic

Series A Round Brings $60m To 89bio Launched with small molecules licensed from Teva Pharmaceutical Industries Ltd. , 89bio concurrently raised $60m through its Series A round. Founding investors O